文章摘要
麝香保心丸联合八段锦对老年冠心病PCI术后Ⅱ期康复患者疗效的影响
Effect of Shexiang Baoxin Pills combined with Baduanjin on therapeutic effect of phase Ⅱ rehabilitation in elderly coronary heart disease patients after PCI surgery
投稿时间:2024-04-30  
DOI:10.3969/j.issn.1000-0399.2024.12.020
中文关键词: 麝香保心丸  八段锦  经皮冠状动脉介入治疗术  老年人  心脏康复
英文关键词: Shexiang Baoxin Pills  Baduanjin  Percutaneous coronary intervention  Elderly people  Cardiac rehabilitation
基金项目:安徽省人文社会科学研究重大项目(编号:SK2020ZD32);安徽省高校科学研究重点项目(编号:2023AH051899);亳州市卫生健康科研项目(编号:bzwj2023c003)
作者单位E-mail
张文科 233030 安徽蚌埠 蚌埠医科大学研究生院
236800 安徽亳州 亳州市人民医院心脏康复中心 
 
程丽芳 236800 安徽亳州 亳州市人民医院心脏康复中心  
任梦婷 233030 安徽蚌埠 蚌埠医科大学研究生院  
梁薇 233030 安徽蚌埠 蚌埠医科大学研究生院  
杨琳 233030 安徽蚌埠 蚌埠医科大学研究生院  
王红雨 233030 安徽蚌埠 蚌埠医科大学体育艺术部 wanghongyu81920@163.com 
摘要点击次数: 582
全文下载次数: 238
中文摘要:
      目的 观察麝香保心丸和八段锦联合治疗对老年冠心病介入术后Ⅱ期康复患者疗效的影响。方法 选取2022年10月至2023年9月就诊于亳州市人民医院心脏康复中心经皮冠状动脉介入治疗(PCI)术后Ⅱ期康复患者72例,采用信封法遮盖患者信息,按就诊顺序编号分为对照组和联合组,每组36例。对照组采用西医常规康复疗法,联合组在对照组基础上增加麝香保心丸和八段锦相结合的康复疗法,进行为期12周的康复治疗。使用6 min步行测试(6MWT)、左室射血分数(LVEF)、左室舒张末内径(LVEDD)、西雅图心绞痛量表(SAQ)、广泛性焦虑问卷7项(GAD-7)和患者健康问卷9项(PHQ-9)评分评估治疗效果。结果 对照组30例、联合组33例完成本研究,康复期间无不良事件发生。两组患者干预前各项指标比较,差异均无统计学意义(P>0.05)。与对照组比较,进行为期12周的康复治疗后,康复组患者LVEF、6 min步行距离(6MWD)均增加(P<0.05),LVEDD、GAD-7、PHQ-9均降低(P<0.05),SAQ各项评分均高于对照组(P<0.05)。两组患者干预前后LVEF、LVEDD、6MWD、SAQ、GAD-7、PHQ-9疗效指标差值比较,差异均有统计学意义(P<0.05)。结论 麝香保心丸和八段锦联合治疗能够改善介入术后Ⅱ期康复患者的心功能,增强其运动耐力,减少其焦虑、抑郁等心理症状,改善其生存质量。
英文摘要:
      Objective To observe the therapeutic effect of the combined treatment of Shexiang Baoxin Pills and Baduanjin on coronary heart disease patients in phase Ⅱ rehabilitation after interventional surgery. Methods From October 2022 to September 2023, 72 patients who attended the Cardiac Rehabilitation Center of Bozhou People’s Hospital for phase Ⅱ rehabilitation after percutaneous coronary interven-tion (PCI), were divided into 36 cases in the control group and 36 cases in the combined group according to the numbering of the order of consultation by using the envelope method to mask the patients’ information. The control group was treated with conventional rehabilitation therapy in Western medicine, and the combined group was treated with a 12-week rehabilitation therapy combining Shexiang Baoxin Pills and Baduanjin on the basis of the control group. The 6-minute walk test (6MWT), left ventricular ejection fraction (LVEF), left ventricular end dia-stolic dimension (LVEDD), Seattle Angina Questionnaire (SAQ), Generalized Anxiety Questionnaire (GAD-7), and Patient Health Question-naire (PHQ-9) scores were used as an assessment of treatment effectiveness. Results The control group (n=30) and the combined group (n=33) completed this study, and no adverse events occurred during the rehabilitation period. There was no statistical significance in the comparison of the pre-intervention indicators between the two groups (P>0.05). Compared with the control group, after 12 weeks of rehabilitation, pa-tients in the combined group showed an increase (P<0.05) in LVEF, 6MWD, but a decrease in LVEDD, GAD-7, and PHQ-9 (P<0.05), and the SAQ scores were higher than the control group (P<0.05). The differences in the efficacy indexes of LVEF, LVEDD, 6MWD, SAQ, GAD-7 and PHQ-9 before and after the intervention between the two groups were statistically significant (P<0.05). Conclusion The combined treatment of Shexiang Baoxin Pills and Baduanjin can improve the cardiac function of interventional rehabilitation patients, enhance their exercise endur-ance, reduce their anxiety, depression and other psychological symptoms, and improve their quality of life.
查看全文   查看/发表评论  下载PDF阅读器
关闭